Nitec Pharma AG - News & Media: Media Contact

Quick Links

Media Contact

Media enquiries should be directed to:
Nitec Pharma AG
Dr. Anders Härfstrand, CEO
Phone: +41 61 715 20 46
info@nitecpharma.com

If you would like to be alerted when a press release is added to this site, please fill in the form below:

Full name:
Occupation:
Country of residence:
E-mail address:

You authorize Nitec to use, store and process any information that you provide to us, including your name, address and e-mail address, as far as is reasonably necessary to provide our services. Nitec agrees to treat your personal information as confidential and to take reasonable steps to ensure that it is not accessible to unauthorized persons.

24/10/2008
Nitec Pharma to present 12-month efficacy and safety data for Lodotra^™ at the annual meeting of the American College of Rheumatology in San Francisco

29/09/2008
Nitec Pharma AG secures funding of CHF 24M from TVM Capital and Deutsche Bank.

12/06/2008
Nitec to present Lodotra^™ 12 month treatment data in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR) in Paris.

22/01/2008
Nitec’s phase 3 results with Lodotra^™ in RA published in current issue of The Lancet.